JP Stock MarketDetailed Quotes

4553 TOWA Pharmaceutical

Watchlist

2915
+115+4.11%

20min DelayMarket Closed Dec 20 15:30 JST

150.17BMarket Cap8.87P/E (Static)

TOWA Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

14.70%62.57B

9.13%227.93B

-12.92%59.61B

22.09%60.93B

17.11%52.85B

20.22%54.55B

26.11%208.86B

71.13%68.45B

15.10%49.91B

14.75%45.13B

Cost of revenue

13.56%39.22B

7.64%146.55B

-17.43%38.64B

21.02%38.76B

21.72%34.62B

19.57%34.54B

42.67%136.15B

98.42%46.79B

28.26%32.03B

28.13%28.44B

Gross profit

16.66%23.34B

11.92%81.38B

-3.17%20.98B

24.01%22.17B

9.25%18.23B

21.36%20.01B

3.60%72.71B

31.93%21.66B

-2.78%17.88B

-2.57%16.69B

Operating expense

11.05%17.67B

-5.15%63.74B

-23.11%16.53B

1.40%15.97B

0.14%15.33B

8.61%15.91B

31.81%67.2B

51.32%21.5B

34.50%15.75B

18.64%15.3B

Operating profit

38.48%5.67B

220.06%17.65B

2,642.59%4.44B

191.04%6.2B

109.89%2.91B

123.09%4.1B

-71.29%5.51B

-92.67%162M

-68.11%2.13B

-67.26%1.39B

Net non-operating interest income (expenses)

-47.03%-272M

-37.54%-850M

-69.70%-224M

-91.87%-236M

23.51%-205M

-94.74%-185M

-178.38%-618M

-85.92%-132M

-161.70%-123M

-415.38%-268M

Non-operating interest income

742.86%59M

470.59%97M

600.00%49M

550.00%26M

275.00%15M

250.00%7M

112.50%17M

133.33%7M

100.00%4M

Non-operating interest expense

72.40%331M

49.13%947M

96.40%273M

106.30%262M

-19.12%220M

97.94%192M

176.09%635M

87.84%139M

159.18%127M

403.70%272M

Net investment income

654.72%800M

34.74%1.6B

122.31%827M

-28.57%325M

4.56%344M

221.21%106M

48.44%1.19B

1.64%372M

147.28%455M

116.45%329M

Gain(Loss) on financial instruments designated as cash flow hedges

-17.82%2.22B

400.00%5.55B

643.54%1.94B

120.52%535M

-23.78%375M

335.59%2.71B

-163.88%-1.85B

-33.33%-356M

-364.94%-2.61B

-36.10%492M

Gain(Loss) on derecognition of available-for-sale financial assets

-1,010.00%-222M

-222M

96.45%-20M

Income from associates and other participating interests

Special income (charges)

-105.00%-9M

139.92%206M

231.25%84M

91.87%-36M

-144.44%-22M

180M

13.86%-516M

91.12%-64M

-1,627.59%-443M

-125.00%-9M

Less:Other special charges

101.67%3M

-139.92%-206M

-113.10%-63M

-42.31%15M

--22M

---180M

637.50%516M

1,750.00%481M

189.66%26M

----

Less:Write off

--6M

----

--21M

----

Other non-operating income (expenses)

-28.81%168M

-42.05%525M

-28.82%326M

-36.78%110M

-172.77%-147M

227.78%236M

24.62%906M

316.36%458M

-30.12%174M

5.21%202M

Income before tax

20.22%8.58B

431.14%24.46B

1,536.76%7.17B

1,770.22%6.9B

54.05%3.25B

189.19%7.14B

-79.30%4.61B

-61.00%438M

-105.11%-413M

-60.39%2.11B

Income tax

29.25%3.09B

244.68%8.29B

1,038.01%2.52B

690.51%2.33B

32.28%1.05B

118.26%2.39B

-62.03%2.4B

5.74%221M

-87.30%295M

-43.28%793M

Net income

15.68%5.5B

634.80%16.17B

2,045.16%4.66B

744.77%4.57B

67.02%2.2B

245.96%4.75B

-86.17%2.2B

-76.26%217M

-112.30%-708M

-66.45%1.32B

Net income continuous operations

15.68%5.5B

634.80%16.17B

2,044.70%4.65B

744.92%4.57B

67.15%2.2B

245.71%4.75B

-86.17%2.2B

-76.26%217M

-112.30%-708M

-66.47%1.32B

Noncontrolling interests

Net income attributable to the company

15.68%5.5B

634.80%16.17B

2,045.16%4.66B

744.77%4.57B

67.02%2.2B

245.96%4.75B

-86.17%2.2B

-76.26%217M

-112.30%-708M

-66.45%1.32B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

15.68%5.5B

634.80%16.17B

2,045.16%4.66B

744.77%4.57B

67.02%2.2B

245.96%4.75B

-86.17%2.2B

-76.26%217M

-112.30%-708M

-66.45%1.32B

Gross dividend payment

Basic earnings per share

15.68%111.64

634.77%328.59

2,049.09%94.56

745.13%92.77

67.04%44.75

245.79%96.51

-86.17%44.72

-76.29%4.4

-112.29%-14.38

-66.46%26.79

Diluted earnings per share

15.68%111.64

634.77%328.59

2,049.09%94.56

744.81%92.7483

67.04%44.75

253.78%96.51

-85.86%44.72

-75.74%4.4

-112.57%-14.3838

-65.70%26.79

Dividend per share

0.00%60

0.00%30

5.26%60

-9.09%30

25.00%30

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	14.70%62.57B	9.13%227.93B	-12.92%59.61B	22.09%60.93B	17.11%52.85B	20.22%54.55B	26.11%208.86B	71.13%68.45B	15.10%49.91B	14.75%45.13B
Cost of revenue	13.56%39.22B	7.64%146.55B	-17.43%38.64B	21.02%38.76B	21.72%34.62B	19.57%34.54B	42.67%136.15B	98.42%46.79B	28.26%32.03B	28.13%28.44B
Gross profit	16.66%23.34B	11.92%81.38B	-3.17%20.98B	24.01%22.17B	9.25%18.23B	21.36%20.01B	3.60%72.71B	31.93%21.66B	-2.78%17.88B	-2.57%16.69B
Operating expense	11.05%17.67B	-5.15%63.74B	-23.11%16.53B	1.40%15.97B	0.14%15.33B	8.61%15.91B	31.81%67.2B	51.32%21.5B	34.50%15.75B	18.64%15.3B
Operating profit	38.48%5.67B	220.06%17.65B	2,642.59%4.44B	191.04%6.2B	109.89%2.91B	123.09%4.1B	-71.29%5.51B	-92.67%162M	-68.11%2.13B	-67.26%1.39B
Net non-operating interest income (expenses)	-47.03%-272M	-37.54%-850M	-69.70%-224M	-91.87%-236M	23.51%-205M	-94.74%-185M	-178.38%-618M	-85.92%-132M	-161.70%-123M	-415.38%-268M
Non-operating interest income	742.86%59M	470.59%97M	600.00%49M	550.00%26M	275.00%15M	250.00%7M	112.50%17M	133.33%7M	100.00%4M	100.00%4M
Non-operating interest expense	72.40%331M	49.13%947M	96.40%273M	106.30%262M	-19.12%220M	97.94%192M	176.09%635M	87.84%139M	159.18%127M	403.70%272M
Net investment income	654.72%800M	34.74%1.6B	122.31%827M	-28.57%325M	4.56%344M	221.21%106M	48.44%1.19B	1.64%372M	147.28%455M	116.45%329M
Gain(Loss) on financial instruments designated as cash flow hedges	-17.82%2.22B	400.00%5.55B	643.54%1.94B	120.52%535M	-23.78%375M	335.59%2.71B	-163.88%-1.85B	-33.33%-356M	-364.94%-2.61B	-36.10%492M
Gain(Loss) on derecognition of available-for-sale financial assets		-1,010.00%-222M	-222M	0			96.45%-20M	0	0
Income from associates and other participating interests
Special income (charges)	-105.00%-9M	139.92%206M	231.25%84M	91.87%-36M	-144.44%-22M	180M	13.86%-516M	91.12%-64M	-1,627.59%-443M	-125.00%-9M
Less:Other special charges	101.67%3M	-139.92%-206M	-113.10%-63M	-42.31%15M	--22M	---180M	637.50%516M	1,750.00%481M	189.66%26M	----
Less:Write off	--6M	----	----	--21M	----	----	----	----	----	----
Other non-operating income (expenses)	-28.81%168M	-42.05%525M	-28.82%326M	-36.78%110M	-172.77%-147M	227.78%236M	24.62%906M	316.36%458M	-30.12%174M	5.21%202M
Income before tax	20.22%8.58B	431.14%24.46B	1,536.76%7.17B	1,770.22%6.9B	54.05%3.25B	189.19%7.14B	-79.30%4.61B	-61.00%438M	-105.11%-413M	-60.39%2.11B
Income tax	29.25%3.09B	244.68%8.29B	1,038.01%2.52B	690.51%2.33B	32.28%1.05B	118.26%2.39B	-62.03%2.4B	5.74%221M	-87.30%295M	-43.28%793M
Net income	15.68%5.5B	634.80%16.17B	2,045.16%4.66B	744.77%4.57B	67.02%2.2B	245.96%4.75B	-86.17%2.2B	-76.26%217M	-112.30%-708M	-66.45%1.32B
Net income continuous operations	15.68%5.5B	634.80%16.17B	2,044.70%4.65B	744.92%4.57B	67.15%2.2B	245.71%4.75B	-86.17%2.2B	-76.26%217M	-112.30%-708M	-66.47%1.32B
Noncontrolling interests
Net income attributable to the company	15.68%5.5B	634.80%16.17B	2,045.16%4.66B	744.77%4.57B	67.02%2.2B	245.96%4.75B	-86.17%2.2B	-76.26%217M	-112.30%-708M	-66.45%1.32B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	15.68%5.5B	634.80%16.17B	2,045.16%4.66B	744.77%4.57B	67.02%2.2B	245.96%4.75B	-86.17%2.2B	-76.26%217M	-112.30%-708M	-66.45%1.32B
Gross dividend payment
Basic earnings per share	15.68%111.64	634.77%328.59	2,049.09%94.56	745.13%92.77	67.04%44.75	245.79%96.51	-86.17%44.72	-76.29%4.4	-112.29%-14.38	-66.46%26.79
Diluted earnings per share	15.68%111.64	634.77%328.59	2,049.09%94.56	744.81%92.7483	67.04%44.75	253.78%96.51	-85.86%44.72	-75.74%4.4	-112.57%-14.3838	-65.70%26.79
Dividend per share	0	0.00%60	0.00%30	0	0.00%30	0	5.26%60	-9.09%30	0	25.00%30
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

Beauty Kadan Holdings

KODAMA CHEMICAL INDUSTRY

4222

440 +22.22%

See the daily top gainer.